0001415889-23-010190.txt : 20230622 0001415889-23-010190.hdr.sgml : 20230622 20230622183911 ACCESSION NUMBER: 0001415889-23-010190 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230621 FILED AS OF DATE: 20230622 DATE AS OF CHANGE: 20230622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Qatanani Mo CENTRAL INDEX KEY: 0001980298 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38501 FILM NUMBER: 231034512 MAIL ADDRESS: STREET 1: 301 BINNEY STREET, 3RD FLOOR STREET 2: C/O SCHOLAR ROCK HOLDING CORP CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Scholar Rock Holding Corp CENTRAL INDEX KEY: 0001727196 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823750435 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-259-3860 MAIL ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 3 1 form3-06222023_100607.xml X0206 3 2023-06-21 0 0001727196 Scholar Rock Holding Corp SRRK 0001980298 Qatanani Mo 301 BINNEY STREET CAMBRIDGE MA 02142 false true false false SVP and Head of Research Common Stock 21000 D Common Stock 22500 D Common Stock 22425 D Common Stock 5125 D Common Stock 33750 D Stock Option (Right to Buy) 26.05 2031-10-26 Common Stock 70000 D Stock Option (Right to Buy) 18.08 2032-02-14 Common Stock 22500 D Stock Option (Right to Buy) 4.86 2032-06-16 Common Stock 22425 D Stock Option (Right to Buy) 7.62 2032-10-10 Common Stock 5125 D Stock Option (Right to Buy) 10 2033-02-13 Common Stock 45000 D Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment vesting on September 15, 2022 and each additional installment to vest annually thereafter; provided the individual continues to have a service relationship with the Company on such vesting date. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment vesting on January 15, 2023 and each additional installment to vest annually thereafter; provided the individual continues to have a service relationship with the Company on such vesting date. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in three annual installments over three years, with the first annual installment vesting on June 15, 2023 and each additional installment to vest annually thereafter; provided the individual continues to have a service relationship with the Company on such vesting date. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment vesting on September 15, 2023 and each additional installment to vest annually thereafter; provided the individual continues to have a service relationship with the Company on such vesting date. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment vesting on February 15, 2024 and each additional installment to vest annually thereafter; provided the individual continues to have a service relationship with the Company on such vesting date. 43,750 shares remain unvested under this stock option. The first vesting event occurred on September 30, 2022 and the remainder will vest in twelve quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date. 15,469 shares remain unvested under this stock option. The first vesting event occurred on April 1, 2022 and the remainder will vest in fifteen quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date. 14,950 shares remain unvested under this stock option. The first vesting event occurred on September 16, 2022 and the remainder will vest in eleven quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date. 4,485 shares remain unvested under this stock option. The first vesting event occurred on January 5, 2023 and the remainder will vest in fifteen quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date. 42,188 shares remain unvested under this stock option. The first vesting event occurred on April 1, 2023 and the remainder will vest in fifteen quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date. /s/ Junlin Ho, Attorney-in-Fact for Mo Qatanani 2023-06-22 EX-24 2 ex24-06222023_100607.htm ex24-06222023_100607.htm

Exhibit 24


LIMITED POWER OF ATTORNEY


The undersigned hereby constitutes and appoints each of Sarah Ashfaq and Junlin Ho, and any designee thereof, signing singly, and with full power of substitution, the undersigned’s true and lawful attorney-in-fact to:


(1)           execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Scholar Rock Holding Corporation (the “Company”), from time to time the following U.S. Securities and Exchange Commission (“SEC”) forms: (i) Form ID, including any attached documents, to effect the assignment of codes to the undersigned to be used in the transmission of information to the SEC using the EDGAR System; (ii) Form 3, Initial Statement of Beneficial Ownership of Securities, including any attached documents; (iii) Form 4, Statement of Changes in Beneficial Ownership of Securities, including any attached documents; (iv) Form 5, Annual Statement of Beneficial Ownership of Securities in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder, including any attached documents; (v) Schedule 13D, (vi) Schedule 13G and (vii) amendments of each thereof, in accordance with the Securities Exchange Act of 1934, as amended, and the rules thereunder, including any attached documents;

(2)           do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5, Schedule 13D, Schedule 13G or any amendment(s) thereto, and timely file such form(s) with the SEC and any securities exchange, national association or similar authority; and

(3)           take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to each such attorney-in-fact, acting singly, full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 or Regulation 13D-G of the Securities Exchange Act of 1934, as amended. The undersigned hereby agrees to indemnify the attorney-in-fact and the Company from and against any demand, damage, loss, cost or expense arising from any false or misleading information provided by the undersigned to the attorney-in-fact.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file such forms with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. This Power of Attorney supersedes any prior power of attorney in connection with the undersigned’s capacity as an officer and/or director of the Company. This Power of Attorney shall expire as to any individual attorney-in-fact if such attorney-in-fact ceases to be an executive officer of the Company.


IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of June 21, 2023.



/s/ Mo Qatanani

 


By: Mo Qatanani



ACTIVE/123574557.1